Alpha-Beta preclinical data

ABTI (Worcester, Mass.) reported initial preclinical data showing enhanced progenitor cell production, and also demonstrated equivalence of a new manufacturing process in a study in healthy human volunteers.

As shown at the Third International Congress on Biological Response Modifiers in Cancun, Mexico, combining Betafectin with sub-therapeutic doses of GM-CSF gave a six- to seven-fold increase in growth of megakaryocyte progenitor cells (the precursors to platelets) compared to GM-CSF or interleukin-3 alone. ...